Neuropathic Pain News and Research

RSS
Neuropathic pain is a type of pain that is caused by damage to the nervous system following an injury or illness and affects approximately 1% of the population.

Further Reading

Drugs designed to curb Rac1 signaling pathway may help relieve inflammatory pain in sufferers

Drugs designed to curb Rac1 signaling pathway may help relieve inflammatory pain in sufferers

Noninvasive FMRI may help evaluate effectiveness of new pain medications

Noninvasive FMRI may help evaluate effectiveness of new pain medications

Opioid medication does not improve physical function in patients with neuropathic pain

Opioid medication does not improve physical function in patients with neuropathic pain

BlueWind completes patient enrolment for Overactive Bladder study to support CE Mark submission

BlueWind completes patient enrolment for Overactive Bladder study to support CE Mark submission

Immune enters into exclusive license with Atlante Biotech for new format of bispecific antibodies

Immune enters into exclusive license with Atlante Biotech for new format of bispecific antibodies

Circuit awarded contract to pursue optogenetic therapies for peripheral nervous system indications

Circuit awarded contract to pursue optogenetic therapies for peripheral nervous system indications

First patient enrolled in Phase 2 clinical trial of Immune's bertilimumab in Ulcerative Colitis

First patient enrolled in Phase 2 clinical trial of Immune's bertilimumab in Ulcerative Colitis

Study opens new doors to research possible treatment for patients suffering from neuropathic pain

Study opens new doors to research possible treatment for patients suffering from neuropathic pain

Bionomics, Merck extend collaboration to develop drug candidates for treatment of chronic and neuropathic pain

Bionomics, Merck extend collaboration to develop drug candidates for treatment of chronic and neuropathic pain

Immune submits Bertilimumab IND application to FDA for treatment of Bullous Pemphigoid

Immune submits Bertilimumab IND application to FDA for treatment of Bullous Pemphigoid

Lonza, Benitec partner to develop scalable manufacturing process for AAV-based viral gene therapies

Lonza, Benitec partner to develop scalable manufacturing process for AAV-based viral gene therapies

Benitec Biopharma initiates new site for ongoing Phase 1/2a TT-034 trial for hepatitis C

Benitec Biopharma initiates new site for ongoing Phase 1/2a TT-034 trial for hepatitis C

Nerve damage caused by leprosy linked to changes in the brain of patients

Nerve damage caused by leprosy linked to changes in the brain of patients

Researchers perform first focused ultrasound treatments in the U.S. for dyskinesia

Researchers perform first focused ultrasound treatments in the U.S. for dyskinesia

Nektar receives $40 million cash payment from first commercial sale of MOVENTIG (naloxegol)

Nektar receives $40 million cash payment from first commercial sale of MOVENTIG (naloxegol)

Medical case report of woman with Channelopathy-associated Insensitivity to Pain Syndrome

Medical case report of woman with Channelopathy-associated Insensitivity to Pain Syndrome

Benitec Biopharma announces closing of U.S. initial public offering of ADSs

Benitec Biopharma announces closing of U.S. initial public offering of ADSs

Benitec prices initial public offering of 1,500,000 American Depositary Shares

Benitec prices initial public offering of 1,500,000 American Depositary Shares

Hiroshima University researchers reveal molecular mechanisms involved in neuropathic pain

Hiroshima University researchers reveal molecular mechanisms involved in neuropathic pain

Immune Pharmaceuticals amends licensing agreement with Endo Pharmaceuticals

Immune Pharmaceuticals amends licensing agreement with Endo Pharmaceuticals